Detection and characterization of circulating cell-free fetal DNA (cffDNA) from maternal circulation requires an extremely sensitive and precise method due to very low cffDNA concentration. In our study, droplet digital PCR (ddPCR) was implemented for fetal RHD genotyping from maternal plasma to compare this new quantification alternative with real-time PCR (qPCR) as a golden standard for quantitative analysis of cffDNA. In the first stage of study, a DNA quantification standard was used. Clinical samples, including 10 non-pregnant and 35 pregnant women, were analyzed as a next step. Both methods' performance parameters-standard curve linearity, detection limit and measurement precision-were evaluated. ddPCR in comparison with qPCR has demonstrated sufficient sensitivity for analysing of cffDNA and determination of fetal RhD status from maternal circulation, results of both methods strongly correlated. Despite the more demanding workflow, ddPCR was found to be slightly more precise technology, as evaluated using quantitative standard. Regarding the clinical samples, the precision of both methods equalized with decreasing concentrations of tested DNA samples. In case of cffDNA with very low concentrations, variance parameters of both techniques were comparable. Detected levels of fetal cfDNA in maternal plasma were slightly higher than expected and correlated significantly with gestational age as measured by both methods (ddPCR r = 0.459; qPCR r = 0.438).

Department of Nephrology 1st Faculty of Medicine Charles University Prague and General Faculty Hospital Prague Czech Republic

Department of Obstetrics and Gynecology 1st Faculty of Medicine and General Faculty Hospital Prague Charles University Prague Czech Republic

Institute for Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague and General Faculty Hospital Prague Czech Republic

Zobrazit více v PubMed

Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, et al. Presence of fetal DNA in maternal plasma and serum. The Lancet. 1997;350(9076):485–7. 10.1016/s0140-6736(97)02174-0 PubMed DOI

Wieacker P, Steinhard J. The prenatal diagnosis of genetic diseases. Deutsches Arzteblatt international. 2010;107(48):857–62. 10.3238/arztebl.2010.0857 PubMed DOI PMC

Tabor A, Vestergaard CHF, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound in Obstetrics and Gynecology. 2009;34(1):19–24. 10.1002/uog.6377 PubMed DOI

Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenatal diagnosis. 2007;27(5):415–8. 10.1002/pd.1700 . PubMed DOI

Flori E, Doray B, Gautier E, Kohler M, Ernault P, Flori J, et al. Circulating cell‐free fetal DNA in maternal serum appears to originate from cyto‐and syncytio‐trophoblastic cells. Case report. Human reproduction. 2004;19(3):723–4. PubMed

Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis. The American Journal of Human Genetics. 1998;62(4):768–75. 10.1086/301800 PubMed DOI PMC

Lo YD, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. The American Journal of Human Genetics. 1999;64(1):218–24. PubMed PMC

Lun FMF, Chiu RWK, Allen Chan KC, Yeung Leung T, Kin Lau T, Dennis Lo YM. Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal DNA in Maternal Plasma. Clinical Chemistry. 2008;54(10):1664–72. 10.1373/clinchem.2008.111385 PubMed DOI

Lo YD, Lau TK, Zhang J, Leung TN, Chang AM, Hjelm NM, et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clinical chemistry. 1999;45(10):1747–51. PubMed

Leung TN, Zhang J, Lau TK, Chan LY, Lo YD. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clinical chemistry. 2001;47(1):137–9. PubMed

Sekizawa A, Jimbo M, Saito H, Iwasaki M, Sugito Y, Yukimoto Y, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clinical chemistry. 2002;48(2):353–4. PubMed

Lo YD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. New England Journal of Medicine. 1998;339(24):1734–8. PubMed

Daniels G, Finning K, Martin P, Soothill P. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox sanguinis. 2004;87(4):225–32. PubMed

Clausen FB, Damkjær MB, Dziegiel MH. Noninvasive fetal RhD genotyping. Transfusion and Apheresis Science. 2014;50(2):154–62. 10.1016/j.transci.2014.02.008 PubMed DOI

Costa J-M, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. New England Journal of Medicine. 2002;346(19):1502-. PubMed

Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YD. Prenatal exclusion of β thalassaemia major by examination of maternal plasma. The Lancet. 2002;360(9338):998–1000. PubMed

Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry. 2009;55(4):611–22. 10.1373/clinchem.2008.112797 PubMed DOI

Huggett JF, Foy CA, Benes V, Emslie K, Garson JA, Haynes R, et al. The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments. Clinical Chemistry. 2013;59(6):892–902. 10.1373/clinchem.2013.206375 PubMed DOI

Diehl F, Diaz LA Jr. Digital quantification of mutant DNA in cancer patients. Current opinion in oncology. 2007;19(1):36–42. PubMed

Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, et al. High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number. Analytical Chemistry. 2011;83(22):8604–10. 10.1021/ac202028g PubMed DOI PMC

Zimmermann BG, Grill S, Holzgreve W, Zhong XY, Jackson LG, Hahn S. Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? Prenatal diagnosis. 2008;28(12):1087–93. 10.1002/pd.2150 . PubMed DOI

Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Analytical chemistry. 2007;79(19):7576–9. PubMed

Lo YM, Lun FM, Chan KC, Tsui NB, Chong KC, Lau TK, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(32):13116–21. 10.1073/pnas.0705765104 PubMed DOI PMC

Tsui NBY, Hyland CA, Gardener GJ, Danon D, Fisk NM, Millard G, et al. Noninvasive fetalRHDgenotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variantRHD(IVS3+1G>A) allele. Prenatal diagnosis. 2013;33(12):1214–6. 10.1002/pd.4230 PubMed DOI

Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem. 2004;50(6):1002–11. 10.1373/clinchem.2003.029835 . PubMed DOI

Dhallan R, Au W-C, Mattagajasingh S, Emche S, Bayliss P, Damewood M, et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. Jama. 2004;291(9):1114–9. PubMed

Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. The Lancet. 2007;369(9560):474–81. 10.1016/s0140-6736(07)60115-9 PubMed DOI

Zhang M, Li T, Chen J, Li L, Zhou C, Wang Y, et al. Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2011;31(5):687–92. 10.1007/s11596-011-0583-0 . PubMed DOI

Manokhina I, Singh TK, Peñaherrera MS, Robinson WP. Quantification of Cell-Free DNA in Normal and Complicated Pregnancies: Overcoming Biological and Technical Issues. PloS one. 2014;9(7):e101500 10.1371/journal.pone.0101500 PubMed DOI PMC

Grootkerk-Tax MGHM, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion. 2006;46(12):2142–8. 10.1111/j.1537-2995.2006.01044.x PubMed DOI

Chan FY, Cowley NM, Wolter L, Stone M, Carmody F, Saul A, et al. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation. Prenatal diagnosis. 2001;21(4):321–6. 10.1002/pd.60 . PubMed DOI

Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenatal diagnosis. 2005;25(11):1040–4. 10.1002/pd.1248 . PubMed DOI

Sanders R, Huggett JF, Bushell CA, Cowen S, Scott DJ, Foy CA. Evaluation of digital PCR for absolute DNA quantification. Anal Chem. 2011;83(17):6474–84. 10.1021/ac103230c . PubMed DOI

Bharuthram A, Paximadis M, Picton ACP, Tiemessen CT. Comparison of a quantitative Real-Time PCR assay and droplet digital PCR for copy number analysis of the CCL4L genes. Infection, Genetics and Evolution. 2014;25:28–35. 10.1016/j.meegid.2014.03.028 PubMed DOI

Hoshino T, Inagaki F. Molecular quantification of environmental DNA using microfluidics and digital PCR. Systematic and Applied Microbiology. 2012;35(6):390–5. 10.1016/j.syapm.2012.06.006 PubMed DOI

Horinek A, Korabecna M, Panczak A, Ulcova GZ, Nouzova K, Calda P, et al. Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: methodology issues and kinetics. Fetal diagnosis and therapy. 2007;24(1):15–21. PubMed

Atamaniuk J, Vidotto C, Tschan H, Bachl N, Stuhlmeier KM, Müller MM. Increased Concentrations of Cell-Free Plasma DNA after Exhaustive Exercise. Clinical Chemistry. 2004;50(9):1668–70. 10.1373/clinchem.2004.034553 PubMed DOI

Haghiac M, Vora NL, Basu S, Johnson KL, Presley L, Bianchi DW, et al. Increased Death of Adipose Cells, a Path to Release Cell-Free DNA Into Systemic Circulation of Obese Women. Obesity. 2012;20(11):2213–9. 10.1038/oby.2012.138 PubMed DOI PMC

Risk Minimization of Hemolytic Disease of the Fetus and Newborn Using Droplet Digital PCR Method for Accurate Fetal Genotype Assessment of RHD, KEL, and RHCE from Cell-Free Fetal DNA of Maternal Plasma

Detection of cell-free foetal DNA fraction in female-foetus bearing pregnancies using X-chromosomal insertion/deletion polymorphisms examined by digital droplet PCR

Two Reliable Methodical Approaches for Non-Invasive RHD Genotyping of a Fetus from Maternal Plasma